FDA DEVICE FACTS
Optilite Hevylite IgM Kappa Kit; Optilite Hevylite IgM Lambda Kit
The Binding Site Group , Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Optilite Hevylite IgM Kappa Kit: The Optilite Hevylite IgM Kappa Kit is intended for the in vitro quantitative measurement of IgM kappa (combined µ heavy and κ light chain) in serum using the Binding Site Optilite analyser. The test result is to be used with previously diagnosed Waldenström’s macroglobulinaemia. The test result should be used in conjunction with other laboratory and clinical findings. This assay has not been established for the diagnosis, monitoring and prognosis of Waldenström’s macroglobulinemia. Optilite Hevylite IgM Lambda Kit: The Optilite Hevylite IgM Lambda Kit is intended for the in vitro quantitative measurement of IgM lambda (combined µ heavy and λ light chain) in serum using the Binding Site Optilite analyser. The test result is to be used with previously diagnosed Waldenström’s macroglobulinaemia. The test result should be used in conjunction with other laboratory and clinical findings. This assay has not been established for the diagnosis, monitoring and prognosis of Waldenström’s macroglobulinemia.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。